Utell. Rate of nitric oxide production by lower alveolar airways of human lungs. J. Appl. Physiol. 86(1): 211-221, 1999.-This report describes methods for measuring nitric oxide production by the lungs' lower alveolar airways (V NO), defined as those alveoli and bronchioles well perfused by the pulmonary circulation. Breath holding or vigorous rebreathing for 15-20 s minimizes removal of NO from the lower airways and results in a constant partial pressure of NO in the lower airways (PL). Then the amount of NO diffusing into the perfusing blood will be the pulmonary diffusing capacity for NO (DNO) multiplied by PL and by mass balance equals V NO, or V NO ϭ DNO(PL). To measure PL, 10 normal subjects breath held for 20 s followed by exhalation at a constant flow rate of 0.83 Ϯ 0.14 (SD) l/s or rebreathed at 59 Ϯ 15 l/min for 20 s while NO was continuously measured at the mouth. DNO was estimated to equal five times the single-breath carbon monoxide diffusing capacity. By using breath holding, PL equaled 2.9 Ϯ 0.8 mmHg ϫ 10 Ϫ6 and V NO equaled 0.39 Ϯ 0.12 µl/min. During rebreathing PL equaled 2.3 Ϯ 0.6 mmHg ϫ 10 Ϫ6 and V NO equaled 0.29 Ϯ 0.11 µl/min. Measurements of NO at the mouth during rapid, constant exhalation after breath holding for 20 s or during rebreathing provide reproducible methods for measuring V NO in humans.
EXHALED NITRIC OXIDE (NO) from the airways of humans has attracted interest as a noninvasive method to detect lung injury (1) . Inflammation of the airways in bronchiectasis and acute asthma increases the concentration of exhaled NO (1, 21) . Decreased levels of NO in the lungs have been proposed as a cause of the pulmonary vasoconstriction observed in primary pulmonary hypertension (6, 29) .
In past studies designed to measure the amount of NO exhaled by the lungs or the concentration in the lungs, little emphasis has been placed on the rapid diffusion of NO produced by the lower alveolar airways, defined as those alveoli and bronchioles well perfused by the pulmonary circulation, into the perfusing blood. A recent theoretical analysis (12) showed that ϳ95% of the NO produced by the lungs' lower alveolar airways will be taken up by the pulmonary circulation. A method of calculating the rate of NO production by these airways was devised on the basis of the prediction that the partial pressure of NO in the lower alveolar airways (PL) will reach a constant value at the end of a period of breath holding or rebreathing for 15-20 s. This constant value is expected because breath holding or rebreathing minimizes removal or delivery of NO to the lower alveolar airways from the larger airways and the environment. Then the amount of NO produced by the lower alveolar airways that enters the air spaces (V NO) will equal the amount diffusing into the perfusing blood and tissues or V NO ϭ PL (DNO) or PL ϭ V NO / DNO (1) where PL is in millimeters mercury, DNO is the diffusing capacity for NO in the lower respiratory tract expressed in milliliters divided by minutes times millimeters mercury, and V NO is in milliliters per minute ( Fig. 1) . Equation 1 assumes the partial pressure of NO in the perfusing blood is negligible. PL can be measured in exhaled samples after breath holding or during rebreathing (12, 18, 21, 30) . V NO can then be calculated because DNO is readily measured directly or is estimated from the carbon monoxide pulmonary diffusing capacity (DL CO ) (2, 10, 25) . Alternatively, PL can be interpreted as the production of NO per unit of diffusing capacity of the lower respiratory tract, thereby obviating the need for measuring DNO or DL CO . In this report, we applied Eq. 1 to obtain the first measurements of V NO in humans. In addition to measurements after breath holding and during rebreathing, we also report values for V NO obtained during steady-state breathing.
METHODS

Calculation of V NO From Breath Holding Followed by a Single Exhalation and by Rebreathing Measurements
After breath holding by a subject for 15-20 s, a rapid exhalation will result in a large flow of gas from the lower airways that should markedly dilute any contamination by NO from the nasopharynx and conducting airways. Then the NO signal measured at the mouth approaches or equals PL (12) . Similarly, during the final seconds of rapid rebreathing for 15-20 s, the large ventilation of the lower airways should minimize contributions from the nasopharynx and conducting airways. To obtain V NO, PL is multiplied by DNO (Eq. 1), which is estimated to equal five times the subject's singlebreath DL CO (2, 10) . DL CO was measured at total lung capacity (TLC) and at 1 liter above functional residual capacity (FRC) in triplicate with automated equipment (P. K. Morgan, Haverhill, MA) by using the method described by Jones and Meade (15) . An estimate for DL CO present at the middle of the tidal volume (VT) during rebreathing and steady-state breathing was obtained by linear extrapolation from the measurements of DL CO at TLC and 1 liter above FRC. This extrapolated value of DL CO was multiplied by five to estimate DNO.
Calculation of V NO from Steady-State Measurements
Detailed derivation of the equations to calculate V NO during steady-state breathing is described in the APPENDIX. In brief, during ventilation at a steady state, mixed expired partial pressure of NO (P E) and VT are measured. From the mixed expired and end-tidal concentrations of CO 2 , dead space volume (VD) is estimated, and PL is calculated with the Bohr equation (4) or
where PI is the inspired partial pressure of NO. PL is then used in the following equation to calculate V NO
where V I is inspired minute ventilation.
Measurement of NO
A rapidly responding chemoluminescence NO analyzer (Sievers NOA, model 270B, Sievers, Boulder, CO) operating at a sampling rate of 250 ml/min measured NO with a specified response time of Ͻ200 ms for a signal 90% of full scale. The analyzer provided 40-400 measurements of the NO concentration per second that could be averaged over any selected time interval. Gas containing 229 parts/billion (ppb) of NO was prepared by diluting gas from a compressed-gas cylinder certified to contain 99,600 ppb of NO in nitrogen (Scott Specialty Gases, Plumsteadville, PA) with room air that was ozonated and charcoal filtered to remove NO and other oxides of nitrogen by using a dynamic calibrator (Monitor Laboratories, Lear Seigler Measurement Controls, Englewood, CA). The NO analyzer was calibrated daily by serial dilutions of the gas containing 229 ppb of NO by mixing with the filtered NO-free air. To obtain gas samples completely free of NO, air from a gas cylinder containing Ͻ2 ppb of NO (Scott Specialty Gases) was passed through a filter constructed from a cylinder of 5.8-cm ID and 19 cm in length (Gas Drying Unit, VWR Scientific, Rochester, NY) packed with potassium permanganate (Purafil, Thermoenvironmental Instruments, Franklin, MA) (7). Flow rate through the filter was 300 ml/min. The calibrating gases were stored in 5-liter Tedlar bags (SKC, Eighty Four, PA) that maintained a NO concentration of 229 ppb within 1.1 Ϯ 1.8 (SD) % during multiple measurements for 90 min.
Because the NO-free air signal could drift as much as 2 ppb in 10 min, NO-free air was measured within 1 min both before and after each measurement of NO in expired gas samples and averaged to obtain the zero-NO signal. The lag time between the volume signal supplied by the spirometer and the NO signal was 0.84 Ϯ 0.06 (SD) s. To determine the lag time, the subject rapidly inspired 3-4 liters of gas containing 1,000 ppb of NO from a Tedlar bag-in-box system (Fig. 2) and then exhaled at a flow rate of 1.5-2.0 l/s. Lag time was considered equal to the difference in time from the initial rise in the volume signal recorded from the potentiometer attached to the wheel of the spirometer to the initial rise in the NO signal sampled at the mouthpiece.
Measurements were made to determine whether the NO analyzer provided a NO signal under dry (ATPD) or wet conditions (ATPS) during the analysis of exhaled and rebreathed gases. Multiple gas samples of NO at concentrations of 1.8-210 ppb that were saturated with water vapor by storage in a Tissot spirometer were measured directly as well as after absorption of water vapor by passage through a column 1.5 cm in diameter by 16 cm in height packed with 6-18 mesh silica gel (J. T. Baker, Phillipsburg, NJ). At 25°C, the dry gas resulted in samples of NO 2.5 Ϯ 1.3 (SD) % greater than the humidified samples compared with the predicted increase of 3.2%. [At 25°C, water vapor pressure (PH 2 O) equals 24 mmHg. At barometric pressure (PB) ϭ 750 mmHg, drying the sample should have increased its concentration by 24/750 or 3.2%.] The recorded NO signal from the expired-gas samples was therefore assumed to provide a measurement at ATPS. Measurements of NO in ppb ATPS were converted to partial pressures of NO in mmHg BTPS by the following relationship: NO (in mmHg BTPS) ϭ PB (NO in ppb ATPS)(PB Ϫ 47)/(PB Ϫ PH 2 O) (10 9 ), where PH 2 O ϭ vapor pressure of water at room temperature (4). For example, when PB ϭ 760 mmHg and PH 2 O ϭ 22.4 mmHg, respectively, at a room temperature of 24°, 1 ppb of NO ϭ 0.735 mmHg ϫ 10 Ϫ6 of NO. To ensure that the NO-free air standard remained at ATPS, the operator exhaled warm humidified gas from the mouth by the inlet of the NO analyzer approximately every 5-10 min so that the walls of the unheated inlet tube were kept moist. The data were processed by using a chart recorder (MacLab Recording Instrument, AD Instruments, Castle Hill, Australia) and stored in a Macintosh LC computer (Apple Computer, Cupertino, CA). Fig. 1 . Diagram of major factors that determine partial pressure of nitric oxide (NO) BTPS in volume of gas contained in airways of lower alveolar respiratory tract (PL; in mmHg). Contamination from upper airways is assumed to be excluded. Ventilation (STPD) to lower alveolar airways (V A; in ml/min) will remove NO from lower respiratory tract if inspired gas contains negligible amounts of NO. Amount of NO removed in ml/min by V A is expressed as V A[PL/(PB Ϫ 47)], where PB is barometric pressure. NO in gases contained in lower alveolar respiratory tract will also diffuse into tissues and blood perfusing lower airways. If partial pressure of NO in perfusing blood is negligible, amount diffusing into blood and tissues will equal PL(DNO), where DNO is diffusing capacity for movement of NO into blood perfusing lower respiratory tract (expressed as ml NO STPD · min Ϫ1 · mmHg NO Ϫ1 ). By breath holding or rebreathing, V A becomes negligible and PL reaches a constant value in 15-20 s (12) . Then production of NO STPD by tissues of lower respiratory tract that diffuses into airways (V NO) ϭ DNO(PL). V NO can then be calculated from product of measurements of PL from exhaled gas samples and measurements or estimates of DNO.
To evaluate sensitivity of the NO measurements, 10 repetitive measurements were made on a gas sample initially containing 2.92 mmHg ϫ 10 Ϫ6 of NO. The analyzer recorded 2.83 Ϯ 0.08 (SD) mmHg ϫ 10 Ϫ6 of NO. A sample initially containing 8.20 mmHg ϫ 10 Ϫ6 of NO resulted in 8.22 Ϯ 0.09 mmHg ϫ 10 Ϫ6 of NO. If the detection limit is assumed to equal twice the SD of the measurements, our analytic technique provides a 95% confidence in detecting a signal change of 0.2 mmHg ϫ 10 Ϫ6 of NO.
Subjects
Measurements of PL and V NO were performed in 10 healthy, nonsmoking subjects, ranging in age from 30 to 72 yr (mean 47 yr). Their mean height was 172 Ϯ 9 cm, and weight was 70 Ϯ 8 kg. Seven were men, and three were women. Spirometry showed values Ͼ80% of predicted for the forced expiratory volume in 1 s, with a mean value of 108% (5). Residual volume (RV) was calculated from measurements of FRC performed with plethysmography (8) , and values of expiratory reserve volume were measured with spirometry. Subjects did not use noseclips during the maneuvers for measuring V NO. This study was approved by the University of Rochester's Research Subjects Review Board.
Protocols for Breathing Maneuvers and Gas Samples
Protocol for breath holding followed by a single exhalation. The subject exhaled to RV through the mouthpiece of the apparatus (Fig. 2) into the room and then turned the four-way valve (Hans Rudolph, Kansas City, MO) to connect the mouthpiece to the bag-in-box system previously filled with room air. The subject then rapidly inhaled to TLC and breath held for 15-20 s to obtain a constant value for PL (12) . At the end of the breath hold, the mouthpiece valve was turned 90°t o the spirometry circuit, and the subject exhaled to RV at a constant rate that was varied from 80 to 2,600 ml/s BTPS (Fig. 3) . Marks on the spirometer bell at 500-ml intervals allowed the subject to gauge the expiratory flow rate. The subject repeated the maneuver if the measured flow rate was not within the targeted range.
Protocol for rebreathing. After the bag-in-box apparatus was filled with a volume of air equal to ϳ90% of the subject's vital capacity, the subject exhaled to RV. The mouthpiece valve was then turned to the bag-in-box, and the subject rapidly inhaled until the bag was empty. The subject then rebreathed a volume of 1.4-3.8 liters at a rate of 8-60 breaths/min for 20-30 s, emptying the bag with each inspiration (Fig. 4) . By watching the volume marks on the spirometer bell, the subject maintained the selected rebreathing volume. The value for PL during rebreathing was measured from the last 3 s of the NO signal after the final exhalation during rebreathing was discarded.
Protocol for steady-state breathing. A mouthpiece attached to a one-way valve assembly (valve no. 2600, Hans Rudolph) permitted the subject to inspire from a 120-liter Tissot spirometer and exhale into a 60-liter Douglas bag (Warren E. Collins, Braintree, MA). After three 2-min runs of tidal breathing to equilibrate the tubing, dead space, and the Douglas bag with expired air, the Douglas bag was emptied, Subject breathes through a 4-way valve that can be connected to room air, a bag in a rigid cylinder, or directly to spirometer. Cylinder is connected to the spirometer equipped with a potentiometer attached to a wheel that sends a voltage proportional to volume to a multichannel recorder. NO analyzer measures NO at the mouthpiece and sends this signal to the recorder. At end of breath hold, valve is turned so subject can exhale directly into spirometer. For rebreathing measurements, subject exhales to residual volume and then inhales contents of bag and rebreathes 1.4-3.8 liters for 15-20 s, emptying the bag with each inspiration. Nasal suction at Ϫ10 cm of water pressure can be applied to 1 naris with a tight-fitting rubber cork.
and the subject performed tidal breathing for 4 min while expired air was collected in the Douglas bag. To determine the dead space-to-VT ratio (VD/VT), end-tidal PCO 2 (PET CO 2 ) was recorded at 30-s intervals by using a CO 2 analyzer (Capnograph IV, Gould Medical BV, Bilthoven, The Netherlands). The NO concentration in the Tissot spirometer at the beginning and end of the maneuver and the NO concentration in the Douglas bag were measured with the NO analyzer. Mixed expired PCO 2 (PE CO 2 ) and mixed expired PO 2 (PE O 2 ) in the Douglas bag and the inspired PCO 2 and PO 2 in the Tissot spirometer were measured by using a blood-gas analyzer (Radiometer ABL 520, Copenhagen, Denmark). Partial pressure of inspired and expired nitrogen in these gas samples was estimated by subtracting PCO 2 , PO 2 , and PH 2 O from the PB. VD/VT was assumed equal to (PET CO 2 Ϫ PE CO 2 )/PET CO 2 (4). The kymograph on the Tissot spirometer provided measurements of V I. Expired minute ventilation was measured by multiplying V I by the ratio of the partial pressure of inspired to expired nitrogen (24) . Volume of NO inspired per minute (V I NO ) was calculated as the product of V I and the NO concentration in the Tissot spirometer. Volume of NO expired per minute (V E NO ) was calculated as expired minute ventilation multiplied by the NO concentration in the Douglas bag.
NO production by the nose during the period of steady-state breathing was measured as described below.
Nasal suction and gas-collection system. Air exhaled through the mouth could be contaminated by the much higher concentrations of NO in the nasopharynx (1, 13, 18, 20) . To determine whether negative pressure in the nasal passages (produced by sucking a continuous gas flow through the nasal passages) could decrease this possible contamination and result in lower values of PL, the steady-state measurements and some of the breath-holding and rebreathing experiments were performed while a continuous flow of room air passed from one nostril to the other by the application of 10 cmH 2 O to one nostril. A rubber cork surrounding copper tubing 1/4 in. in OD and 5 cm in length was fitted snugly to one nostril (Fig. 2 ). Tygon tubing (3/8-in. OD, Norton Plastics, Pittsburgh, PA) connected the cork to a T-shaped stopcock valve (no. 0211045, Warren E. Collins) that could connect the cork directly to a source of Ϫ10 cmH 2 O pressure (Chest tube drainage set-up, Atrium Medical, Hudson, NH) or a 19-liter bag-in-box with Ϫ10 cmH 2 O applied to the box. The negative pressure was applied 2 min before as well as during the measurements of PL. For all of the steady-state measurements, the amount of NO expired by the nose (V nose ) was measured by connecting Fig. 3 . Recording of NO concentration and volume signal during 20 s of breath holding followed by exhalation at a flow rate of 500 ml/s. Note rapid initial peak in NO signal to 27 mmHg ϫ 10 Ϫ6 at start of exhalation followed by a constant value of 3 mmHg ϫ 10 Ϫ6 . Peak is attributable to accumulation of NO in posterior pharynx and conducting airways during breath holding that is then flushed through the mouthpiece at start of exhalation. To measure constant value of NO observed during exhalation that follows peak concentration, we compared discarding an initial exhaled volume equal to either 3 or 4 times subject's predicted anatomic dead space [DS; (hatched areas)] plus instrument's dead space of 100 ml. The final 10% of exhalation was discarded (10% volume). The remaining volume after 3 times the dead space was discarded and was divided into 3 equal volumes (PL 1 , PL 2 , and PL 3 ) as well as the sum of these intervals (PL 1 -PL 3 ). NO concentrations were also calculated after 4 times the dead space and the last 10% of exhalation (PL 4 ) were discarded. NO signal in figure was left shifted to correct for lag time of NO analyzer. the tubing from the nostril to the bag-in-box during steadystate breathing. By measuring the concentration of NO in room air and in the collecting bag, as well as the volume and length of time the gas was collected in the bag, the rate of V nose could be calculated.
Specific Experiments
Selection of expired samples after breath holding. During breath holding, high concentrations of NO accumulate in the upper airways (30) and appear as an initial peak during subsequent exhalation (Fig. 3 ). This peak is followed by a constant value that is assumed to represent the concentration of NO in the expirate from the lower alveolar airways. To select this value without contamination from the peak level, we discarded from analysis an initial expired volume equal to three or four times the subject's anatomic dead space estimated to equal (in cm) the ideal body weight (in lb.) (4), plus the instrument's dead space of 100 ml. We also discarded the final 10% of the volume of the expired breath because the NO concentration usually increased with the slowing of expiratory flow near the end of the breath. The exact increments of volume analyzed to select a part of the exhalation not contaminated by the initial NO peak are shown in Fig. 3 .
Effect of continuous nasal suction with Ϫ10 cmH 2 O. To determine whether nasal suction reduced contamination of PL from NO in the nasopharynx, we compared breath-holding and rebreathing measurements performed on the same day with and without nasal suction.
Comparison of breath-holding and rebreathing maneuvers to determine PL. The subjects performed the breath-holding and rebreathing maneuvers in triplicate on the same day. For breath holding, PL was determined after a volume four times the sum of the subject's dead space and the instrument's dead space (PL 4 in Fig. 3 ) was discarded.
Effect of expiratory flow rates on breath-holding measurements of PL. Exhaled NO levels measured at the mouth progressively increase with slower expiratory flow rates (30) . To determine the rapidity of expiratory flow rates required to obtain a stable, constant value for PL not influenced by changes in the expiratory flow rate, five subjects performed breath-holding maneuvers followed by exhalations at constant flow rates that varied between 80 and 2,600 ml/s BTPS. PL was measured after an initial volume equal to four times the dead space (PL 4 in Fig. 3 ) was discarded. However, at expiratory flow rates Ͼ900 ml/s, the initial expiratory peak was not separated from the subsequent plateau after a volume four times the dead space was discarded. For these measurements at flow rates Ͼ900 ml/s, PL was calculated from data recorded after the peak had disappeared.
Effect of different ventilatory rates on PL measured during rebreathing. In five subjects, the ventilatory rate during rebreathing was varied by changing the breathing rate from 8 to 60 breaths/min while keeping the volume rebreathed constant at 1.4-3.8 liters BTPS. To obtain ventilatory rates as high as 145 l/min, subjects also rebreathed as deep and fast as possible (maximum voluntary ventilation maneuver). Measurements were performed in triplicate.
Effect of varying alveolar lung volume on rebreathing measurements of PL. Five subjects rebreathed 1.6 liters at 25 breaths/min and changed their alveolar volume by starting the rebreathing maneuver at either 1 liter above RV or two liters below TLC.
Intraday and interday variation of PL in five subjects during breath holding and rebreathing. Intraday variations in PL were determined from three measurements made on the same day. Interday variation was calculated from the mean of three or more measurements made on three to five different days.
Statistical Methods
In all experiments, subjects served as their own control so that results were compared with control measurements by using a two-tailed paired t-test. For each set of control measurements and interventions, measurements of PL were made in triplicate and the mean values were compared. A level of P Ͻ 0.05 was required for statistical significance.
RESULTS
Selection of Expired Gas Samples
After Breath Holding Table 1 shows the mean values for PL in five subjects obtained from various segments of the expiratory curve for NO described in Fig. 3 . The various expired samples showed little difference from each other with the exception of PL 1 , the first of three segments analyzed after a volume equal to three times the dead space was discarded. PL 1 was significantly greater than the later segments (P Ͻ 0.05 with nasal suction, P Ͻ 0.02 nonsuction). PL 4 , data collected after the discarding of a volume equal to four times the dead space, was slightly lower than PL [1] [2] [3] , the data collected after the discarding of a volume three times the dead space, but this difference was only significant without nasal suction (P Ͻ 0.02). However, differences were small between PL 4 vs. PL 1-3 , being only 0.2 mmHg ϫ 10 Ϫ6 with nasal suction and 0.4 mmHg ϫ 10 Ϫ6 without nasal suction. In the subsequent measurements of PL by breath holding, PL 4 was chosen because of the theoretical advantage of less influence from contamination by the NO peak at the start of exhalation and the inclusion of a larger number of data points than were obtained with either PL 2 or PL 3 . Table 2 shows that, despite suctioning of air through the nasal passages, PL with breath holding or rebreathing showed no significant change. Values are means Ϯ SD in mmHg ϫ 10 Ϫ6 BTPS. NO, nitric oxide; PL, partial pressure of NO in lower alveolar airways. Subscript nos., expirate segments (for definition of segments, see Fig. 3) ; suction, measurements performed while room air was suctioned continuously from 1 nostril at Ϫ10 cmH 2 O. Expiratory flow rates were 488 Ϯ 48 (SD) ml/s BTPS ranging from 432 to 553 ml/s. * P Ͻ 0.05 compared with other segments. † P Ͻ 0.02 compared with PL 1-3 . 215 nasal suction in 10 subjects. Individual values are illustrated in Fig. 5 . The expiratory flow rate after breath holding equaled 830 Ϯ 141 ml/min (range: 640-1,160 ml/min), and minute ventilation with rebreathing equaled 59 Ϯ 15 l/min (range: 41-86 l/min). The steady-state values were measured on different days in five of the subjects while using nasal suction. Rebreathing values for PL were 0.6 Ϯ 0.6 mmHg ϫ 10 Ϫ6 less than observed during breath holding (P Ͻ 0.001). PL of 7.1 Ϯ 2.5 mmHg ϫ 10 Ϫ6 measured during steady-state breathing in five subjects significantly exceeded the rebreathing measurements of 2.3 Ϯ 0.6 mmHg ϫ 10 Ϫ6 (P Ͻ 0.02) and the breath-holding measurements of 2.9 Ϯ 0.8 mmHg ϫ 10 Ϫ6 (P Ͻ 0.04), suggesting the more leisurely flow rates with steadystate breathing were not effective in minimizing contamination of the expired samples by NO generated in the upper airways. Figure 6 shows PL obtained after breath holding by using different constant expiratory flow rates that varied between 80 and 2,600 ml/s. As previously reported by Silkoff and co-workers (30), PL progressively increased as expiratory flow rates were reduced. These data show that PL remained constant once flow rates exceeded 550 ml/s.
Effects of Continuous Nasal Suction with Ϫ10 cmH 2 O
Comparison of Measurements of PL by Breath Holding, Rebreathing, and Steady-State Breathing
Effects of Expiratory Flow Rates on PL Obtained After Breath Holding in Five Subjects
Effect of Changes in Minute Ventilation on PL Measured by Rebreathing in Five Subjects
By varying the rebreathing rate while keeping VT at 1.4-3.8 liters, the effects of minute ventilation on PL were determined. In addition, subjects performed the maximum voluntary ventilation (MVV) maneuver to obtain values of PL at ventilatory rates from 75 to 145 l/min. Figure 7 shows that a minute ventilation greater than ϳ35 l/min results in stable values for PL. Data obtained during MVV did not significantly differ from data obtained by rebreathing 1.4-3.8 liters at minute ventilations Ͼ35 l/min. PL equaled 2.1 Ϯ 0.5 mmHg ϫ Fig. 5 . Individual values for PL in 10 subjects measured by rebreathing and breath holding on same day. Five of the subjects had measurements of PL during resting steady-state breathing on separate days. Values are means Ϯ SD. DNO, pulmonary diffusing capacity for NO; V NO, rate of NO production in lower alveolar airways. V NO was calculated from product of PL and estimated value for DNO. *DNO was estimated to equal 5 times the measured value for the pulmonary diffusing capacity for CO adjusted to the alveolar volume during rebreathing, breath holding, or steady-state breathing. See text for details. † P Ͻ 0.001 compared with breath holding. ‡ P Ͻ 0.04 compared with breath holding and P Ͻ 0.02 compared with rebreathing. § P ϭ 0.07 compared with breath holding and P Ͻ 0.01 compared with rebreathing. 
Effects of Varying Alveolar Lung Volume on Rebreathing Measurements of PL
To see whether increases in alveolar lung volume altered PL during rebreathing, five subjects rebreathed 1.4 to 1.9 liters at 25 breaths/min, starting at either 1 liter above RV or 2 liters below TLC. The resultant thoracic lung volume at the midpoint of rebreathing was 3.1 Ϯ 1.0 liters BTPS at the lower lung volume and 4.4 Ϯ 1.6 liters BTPS at the higher lung volume. Values for PL at the lower lung volume were 2.9 Ϯ 0.7 mmHg ϫ 10 Ϫ6 and 2.8 Ϯ 0.6 mmHg ϫ 10 Ϫ6 of NO at the higher volumes. They did not differ significantly (P ϭ 0.8).
Rate of V NO by the Lower Alveolar Respiratory Tract in Humans
To determine the rate of V NO by the lower alveolar respiratory tract of humans, 10 healthy subjects had breath-holding and rebreathing measurements of PL without nasal suction as well as measurements of DL CO .
Five of the subjects had measurements during steadystate breathing. For the breath-holding measurements, subjects exhaled at 640-1,156 ml/s. For the rebreathing measurements, they rebreathed 40-85 l/min. Table 3 shows that the breath-holding measurements of V NO of 0.39 Ϯ 0.2 µl/min were 29% greater than the rebreathing measurements of 0.29 Ϯ 0.12 µl/min (P Ͻ 0.001). Steady-state measurements of V NO of 0.74 Ϯ 0.25 µl/min were approximately twice as great as the rebreathing measurements (P Ͻ 0.01) and breathholding measurements (P ϭ 0.07). Table 4 shows values for lower alveolar respiratory tract NO production (V NO), net NO exchange with the environment, and nasal NO removal (V nose ) in five subjects during resting tidal breathing. Subjects 1, 2, and 5 were studied on days with low levels of environmental NO (1.4, 1.2, and 4.6 mmHg ϫ 10 Ϫ6 of NO). They exhaled more NO than they inspired. Subjects 3 and 4 inhaled 13.2 and 9.6 mmHg ϫ 10 Ϫ6 of NO, respectively, and absorbed NO from the environment. V nose of 0.44 Ϯ 0.20 µl/min was less than V NO of 0.74 Ϯ 0.20 µl/min, but the difference was not significant (P ϭ 0.14). Ninety-five percent or more of the calculated value of V NO was absorbed by the respiratory tract, and only 5% or less of V NO was exhaled. Table 5 shows the intraday and interday variability of PL measured during breath holding and rebreathing in five subjects expressed as the coefficient of variation (CV). Breath-holding measurements had an intraday CV of 9 Ϯ 2% compared with 8 Ϯ 3% with rebreathing and did not differ significantly (P ϭ 0.6). The interday CV was 24 Ϯ 7% with breath holding and 26 Ϯ 9% with rebreathing, respectively. This difference was not significant (P ϭ 0.8).
Resting Steady-State Measurements of Respiratory Tract NO Exchange
Intraday and Interday Variability of PL
DISCUSSION
These experiments show that the lower alveolar airways, defined as the alveoli and respiratory bronchioles well perfused by the pulmonary circulation, have a V NO of 0.39 Ϯ 0.12 µl/min, determined from rapidly expired samples collected after 15-20 s of breath holding and 0.29 Ϯ 0.11 µl/min measured during rebreathing. The steady-state measurements shown in Table 4 and theoretical analyses (12) show that only ϳ5% of V NO is expired and 95% is taken up by the tissues of the airways and perfusing blood flow. As a result, V NO is substantially greater than the amount of NO in mixed expired samples of resting subjects. For example, the five subjects in Table 4 Despite the large surface area of the lower alveolar airways, on the order of 70 m 2 (33) , these values for V NO are similar to the net amount of V nose of 0.44 Ϯ 0.20 µl/min in five of our subjects, 0.32 Ϯ 0.09 µl/min reported by Imada and co-workers (13), and 0.22 Ϯ 0.02 µl · min Ϫ1 ·m Ϫ2 by Kimberly and co-workers (18) in eight normal subjects. However, V NO is more than fivefold greater than the amount of NO produced by the larger conducting airways extending from above the respiratory bronchioles to the mouth [0.05 Ϯ 0.02 (SD) µl/min]. This value was calculated from measurements of expired NO after breath holding. These were made by using multiple exhalations at different expiratory flow rates in five normal subjects, as described in a preliminary report by Perillo and co-workers (26) .
Comparison With Measurements by Others
There are no reported previous measurements of V NO to compare with our values, but several groups have measured the concentration of NO in expired gas samples collected in a manner that suggest the NO came primarily from the lower alveolar airways. In 10 subjects, after a 30-s breath hold that should result in a constant value for PL, Silkoff and co-workers (30) reported 2.3 Ϯ 0.1 mmHg ϫ 10 Ϫ6 of NO in samples exhaled at 1,550 ml/s. They did not scrub their reference gas of NO through potassium permanganate, which we find decreases the zero reference signal by ϳ0.5 mmHg ϫ 10 Ϫ6 . Therefore, the concentration of NO their subjects actually exhaled was likely ϳ2.8 Ϯ 1.1 mmHg ϫ 10 Ϫ6 . This value is similar to our post-breathholding PL values of 2.9 Ϯ 0.8 mmHg ϫ 10 Ϫ6 (Table 3) . NO in gas samples suctioned from the bronchial lumen after tracheal intubation should supply gases not contaminated with the high concentration of NO in the nasopharynx. Tsujino and co-workers (32) observed 3.5 Ϯ 0.7 mmHg ϫ 10 Ϫ6 of NO in expired samples collected from the lumen of a cuffed endotracheal tube after the first 200 ml of the expired gas in six normal subjects were discarded. Lundberg and co-workers (20) observed 2.2 Ϯ 0.7 mmHg ϫ 10 Ϫ6 of NO in exhaled air collected from the stoma of four adults with chronic tracheostomies. Collectively, the above data indicate that the PL in normal humans is on the order of 3 mmHg ϫ 10 Ϫ6 .
Minimizing Errors in Measurements of V NO from Contamination by NO in the Nasopharynx
Accurate measurements of V NO depend on collection of alveolar gas samples free of contamination from the high concentrations of NO in the nasopharynx. To evaluate possible nasopharyngeal contamination of expired and rebreathed gas samples, we compared measurements of PL made with and without continuous application of Ϫ10 cmH 2 O pressure to one nostril. This nostril (Table 4 ) and would be expected to lower the concentration of NO in the nasopharynx. Also, the nasal suction should result in negative pressure in the posterior nasopharynx, thereby closing the velum to the oropharynx and making any leak across the velum move gases into the nasopharynx. However, this negative pressure did not significantly change values of PL. These results indicate that nasopharyngeal contamination was minimal during the breath-holding and rebreathing maneuvers. The similarity of our values of PL to measurements of NO collected from the airways of subjects breathing through cuffed endotracheal tubes that should eliminate nasopharyngeal contamination (21, 32) also suggests that the breath-holding and rebreathing maneuvers used in this study prevented significant nasopharyngeal contamination. Other investigators have employed positive airway pressure during breath holding and exhalation to prevent nasopharyngeal contamination (30) , and as little as ϩ5 cmH 2 O of positive pressure is considered sufficient to prevent contamination (16) . Recently, experiments have shown that breath holding even without positive pressure prevents contamination of the oropharynx by the high concentrations of NO in the nasopharynx (17) .
Potential Errors in Measurements of V NO From NO Produced in the Conducting Airways
NO produced in the conducting airways will mix with the expired gas from the lower alveolar airways and thereby raise its concentration during exhalations after breath holding as well as during rebreathing. This source of error is minimized by taking advantage of the large amounts of gas flow available from the alveolar compartment that can markedly dilute the amount of NO being produced by the conducting airways. Figure 6 shows that values for PL measured at the mouth after breath holding become constant at expiratory flow rates exceeding 550 ml/s. Therefore, in normal subjects, expiratory flow rates Ͼ550 ml/s appear to diminish the contribution from the conducting airways sufficiently to minimize errors in PL from NO generated in the conducting airways. Similarly, during rebreathing, large ventilatory rates will dilute the NO produced by the conducting airways by the rebreathed gases. Figure 7 shows that PL during rebreathing becomes essentially constant at ventilatory rates Ͼ35 l/min. This finding suggests the contribution of NO from the conducting airways in normal subjects is sufficiently diluted by ventilatory rates Ͼ35 l/min to cause insignificant changes in PL.
Cause of Higher Values for V NO Measured After Breath Holding Compared With Rebreathing Measurements
Measurements of PL after breath holding were 22% greater than rebreathing measurements (Table 3) . This finding can be explained by the accumulation of NO produced by the conducting airways in their air spaces during breath holding. Because this NO is not washed away by ventilation, it will diffuse into the tissues of the conducting airways. During the subsequent expiration, it will diffuse back into the lumen of the conducting airways and raise the NO concentration in gases entering from the lower alveolar airways. In contrast, during rebreathing, the constant mixing between the rebreathing bag and the airways should prevent accumulation of high concentrations of NO in the conducting airways and result in smaller amounts of NO diffusing out of the tissues of the conducting airways into the rebreathed gases. The diffusion of NO out of the tissues of the conducting airways into the gas lumen will make the expired NO concentration higher than the true alveolar concentration with both maneuvers, but this source of error should be smaller with the rebreathing method.
Steady-State Estimates of PL and V NO
Calculations of PL and V NO from mixed expired samples collected during steady-state breathing resulted in values of PL and V NO that were twice those obtained with rebreathing at a rate Ͼ41 l/min or after breath holding at expiratory flow rates in excess of 640 ml/min shown in Table 3 and Fig. 5 . A logical explanation is that the dead space fraction of ϳ200 ml/breath will contain NO being produced by the conducting airways. During the slower exhalation during steadystate breathing, a larger amount of NO will accumulate in the dead space fraction and contribute more NO to the mixed expired gas and increase the size of PL calculated with Eq. 2. The equations for measuring PL during steady-state breathing do not take into account the NO being produced by the conducting airways and thereby lead to an overestimation of V NO and PL. Data obtained during steady-state ventilation are therefore not suitable for determining V NO or PL with Eqs. 2 and 3.
Potential Errors in V NO From Assuming Partial Pressure of NO in the Perfused Blood (Pc) is Negligible
NO produced in the lower alveolar airways diffuses into the blood perfusing these airways, where it rapidly combines with reduced hemoglobin, other combining sites on the hemoglobin molecule, as well as with proteins in plasma and lung tissue (14, 19) . If these reactions lower the concentration of NO in the blood to negligible levels, calculation of V NO with Eq. 1 stating V NO ϭ PL(DNO) is correct. However, if Pc is not negligible, Eq. 1 becomes (12)
To determine whether Pc is larger enough to cause significant errors in V NO calculated with Eq. 1, we have initiated in vitro estimates of Pc (28) . Fifty milliliters of blood are incubated in a Tedlar bag at 37°C containing 2,500 ml of gas at a PCO 2 of 40 Torr, PO 2 of 100 Torr, and a partial pressure of NO (PNO bag ) of 40 mmHg ϫ 10 Ϫ6 . PNO bag is measured every 10 min. In four sets of measurements of PNO bag containing blood from four healthy subjects, PNO bag initially fell exponentially, until reaching a constant value of 0.4 Ϯ 0.2 (SD) mmHg ϫ 10 Ϫ6 at 50 min. At the present time we know of no other estimates of Pc. Because PL is on the order of 3 mmHg ϫ 10 Ϫ6 , these preliminary data suggest V NO should be calculated with Eq. 4, multiplying DL NO by 3 Ϫ 0.4 or 2.6 mmHg ϫ 10 Ϫ6 in place of 3.0 mmHg ϫ 10 Ϫ6 . These observations suggest the V NO calculated with Eq. 1, which assumes Pc is zero, overestimates its true value by ϳ15% in normal subjects. If V NO is measured in diseased subjects, measurements of Pc will be required to determine whether Pc is large enough to cause significant overestimates of V NO calculated with Eq. 1 that assumes Pc is negligible.
Fraction of Total V NO Measured with Eq. 1
This method of measuring V NO assumes NO produced in the tissues of the lower airways enters the air spaces and then diffuses into the perfusing blood and tissues. Some NO produced in these tissues will react with substances in the tissues and never enter the air spaces. NO produced in bronchioles and small bronchi may be taken up by blood in the bronchial circulation or by other tissues without entering the air spaces (19) . Because these forms of NO produced by the lower alveolar airways do not enter the air spaces and contribute to PL, they will not be measured with Eq. 1. Therefore, total V NO may be considerably higher than 0.3 to 0.4 µl/min calculated with Eq. 1. We are unaware of methods that can measure both the airway-exchangeable and -nonexchangeable components of NO produced by the lower airways.
Importance of Measurements of DNO
According to Eq. 1, PL can be interpreted as V NO per unit of DNO. If the process or disease being studied does not alter DNO, PL is proportional to V NO, and direct measurements or estimates of DNO add little information. However, if the intervention or disease has the potential of changing DNO, such as a decrease secondary to acute lung injury or passive lung hyperinflation (12) , or an increase with heavy exercise, PL can change its value secondary to the change in DNO with no alteration in V NO. Therefore, direct measurements of DNO at the time PL is measured will be required to make accurate measurements of V NO if the process or disease being studied can significantly alter DNO. In summary, these experiments show that the NO concentration measured at the mouth during moderately vigorous rebreathing or forceful exhalation can provide data to calculate NO produced by the lower alveolar airways that enters the air spaces. This technique is sufficiently reproducible to determine whether factors that increase expired NO, such as positive end-expiratory pressure (3, 7, 27) and elevated pH (3), or that decrease expired NO, such as hypoxia (3, 7, 9) , are associated with a similar change in V NO. Other potential applications include studies in patients with diseases suspected of causing overproduction of NO, such as asthma (1, 21) and cirrhosis of the liver (22, 31) , and underproduction of NO described in primary pulmonary hypertension (6, 29) . Some drugs designed to reduce lung inflammation lower NO production (11) so that measurements of V NO or PL may have application in monitoring responses to therapeutic interventions designed to reduce lung inflammation. 
During ventilation at a steady state, mixed expired NO concentration (PE) and VT can be measured and PL can be calculated from PE and PI by the Bohr equation (4) PE (VT) ϭ PI (VD) ϩ PL (VT Ϫ VD) ( A5)
where the left-hand term PE (VT) is proportional to total NO in an exhaled breath, and the right-hand terms represent the contributions from the dead space (VD) and the lower airways (VT Ϫ VD), respectively. Solving for PL gives PL ϭ PE (VT) Ϫ PI (VD)
VT Ϫ VD (A6)
PL is then used in Eq. A4 to determine V NO during steadystate breathing. The extrapolated volume for DL CO present at the middle of the VT during steady-state breathing was multiplied by five to provide a value for DNO used in Eq. A4. VD was calculated from measurements of inspired, end-tidal, and mixed expired CO 2 concentrations (4). V E was determined from the product of V I measured from the Tissot spirometer multiplied by the inspired nitrogen concentration and divided by the expired nitrogen concentration (24) .
